UAE Multiomics Market Size & Outlook, 2023-2030
UAE multiomics market, 2018-2030 (US$M)
Related Markets
UAE multiomics market highlights
- The UAE multiomics market generated a revenue of USD 11.5 million in 2023 and is expected to reach USD 25.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2023 | USD 11.5 million |
| Market revenue in 2030 | USD 25.0 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global multiomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia multiomics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 25.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 56.52% in 2023. Horizon Databook has segmented the UAE multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE witnessed the emergence of biotechnology and pharmaceutical companies that were increasingly interested in multiomics research. For instance, in November 2022, Illumina Inc., a prominent global leader in DNA sequencing and array-based technologies, launched a new state-of-theart Solutions Center in Dubai.
The Solutions Center signifies an expansion of the company's financial commitment and support in UAE with the potential to substantially advance the utilization of genomics in improving human health. Moreover, in October 2022, G42 Healthcare, a UAE-based AI-health tech company, announced a partnership with Saphetor SA to strengthen its clinical genomic offering.
In addition to this partnership, the company has expanded its offerings to make personalized treatment more feasible in the UAE. Furthermore, in May 2020, the BGI group and ICBA collaborated to establish a dedicated, cutting-edge genomics center in the UAE.
Reasons to subscribe to UAE multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE multiomics market , including forecasts for subscribers. This country databook contains high-level insights into UAE multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE multiomics market size, by product & service, 2018-2030 (US$M)
UAE Multiomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
